BIT 6.67% 3.2¢ biotron limited

HIV, SA variant and BIT225, page-429

  1. 5,354 Posts.
    lightbulb Created with Sketch. 654
    Also these were “humanised mice” designed to be infected with Covid 19 to test for the efficacy of BIT225.
    Study shows almost 100% efficacy.

    Now the reason Biotron is likely to be accepted straight into a phase 2 human trials is because the drug has a very good safety profile and is currently being used in 2 HIV studies on humans right now.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.002(6.67%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.1¢ 3.3¢ 3.1¢ $13.79K 424.2K

Buyers (Bids)

No. Vol. Price($)
1 329429 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 100000 1
View Market Depth
Last trade - 15.51pm 26/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.